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1. Introduction   
The World Health Organization estimates that more than 220 million people worldwide 
have diabetes mellitus (DM). This figure is estimated to more than double by 2030 (Wild 
et al., 2004). In Japan, the number of diabetic patients has increased to 8 million, and it is 
assumed that 35% to 45% of diabetic patients have diabetic symmetric polyneuropathy 
(DPN). Advanced DPN causes serious complications, such as diabetic foot ulcers, 
gangrene, and Charcot joint, all of which worsen the quality of life of diabetic patients 
(Ogawa et al., 2006). Therefore, early detection of nerve dysfunction is important to 
provide appropriate care for patients with DPN (Chudzik et al., 2007). The diagnosis of 
diabetic neuropathy is based primarily on characteristic symptoms and is confirmed with 
nerve conduction studies (NCS), which are time-consuming, slightly invasive, and 
occasionally not well tolerated for repeated evaluations (Colak et al., 2007). In contrast, 
ultrasonographic examinations can be performed to assess peripheral nerves with less 
discomfort and have already been used for the evaluation of several disorders of the 
peripheral nervous system such as carpal tunnel syndrome (Wiesler et al., 2006a; Abe et 
al., 2004; Jayaraman et al., 2004; Duncan et al., 1999; Lee et al., 1999), cubital tunnel 
syndrome (Okamoto et al., 2000; Wiesler et al., 2006b), and traumatic nerve lesions 
(Cartwright., 2007; Peer et al., 2001). High-resolution diagnostic ultrasonography (US) has 
improved greatly, allowing for evaluation of minute peripheral nerves (Fornage., 1993; 
Solbiati et al., 1985). We previously showed that the cross-sectional area (CSA) of the 
median nerve in the carpal tunnel of patients with DPN is greater than that of controls 
and correlates with NCS (Watanabe et al., 2009). Furthermore, it appears that the 
percentage of the hypoechoic area of the peripheral nerves was significantly greater in 
patients with lower motor nerve conduction velocity (MCV) and DM than in controls or 
patients with higher MCV and DM (Watanabe et al., 2010). 
The purpose of this chapter is to review the current knowledge regarding the overview and 
diagnosis of the most common forms of neuropathy in type 2 DM. Furthermore, our current 
sonographic technique and preliminary studies are presented for some cases. In this chapter, 
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we focus mainly on a simple and noninvasive approach to the evaluation of peripheral 
nerves in patients with type 2 DM. Although the exact mechanisms contributing to our 
study have not been clearly identified and are not the main focus of this chapter, they will 
be discussed in brief. 
2. Clinical aspects of diabetic neuropathy 
Diabetic neuropathy is a neuropathic disorder that is associated with DM. This condition is 
thought to result from both diabetic microvascular injury involving small blood vessels that 
supply nerves and macrovascular conditions that can culminate in DM. More than 80% of 
patients with clinical diabetic neuropathy have a distal, symmetrical form of the disorder 
(Said., 2007). In general, the symptoms included numbness, burning feet, pins-and-needles 
sensations, and lightning pains. These symptoms start in the feet go on to affect more 
proximal parts of the lower limbs, and eventually affect the distal parts of the upper limbs.  
The unified clinical criteria and classification for DPN do not represent the international 
standard because the causes of peripheral nerve disorders associated with DM are complex 
and probably involve a variety of causative mechanisms. In this chapter, DPN is classified 
into 3 groups (hyperglycemic neuropathy, symmetric polyneuropathy, and focal and 
multifocal neuropathy) according to the classification of the Thomas et al (1997). This 
classfication is the easiest. The most common of these groups seen in the clinical setting is  
symmetric distal polyneuropathy. 
3. Pathology of diabetic neuropathy 
Abnormalities reported in diabetic neuropathy include axonal degeneration in nerve fibers, 
primary demyelination resulting from Schwann cell dysfunction, secondary segmental 
demyelination related to impairment of axonal control of myelination, remyelination, 
proliferation of Schwann cells, atrophy of denervated bands of Schwann cells, onion-bulb 
formations, and hypertrophy of the basal lamina. Early morphological changes include 
minimal alteration of myelinated and unmyelinated fibers and axonal regeneration 
(Yagihashi et al., 2007; Said et al., 2007).  
The pathophysiology of DPN is multifactorial and involves genetic, environmental, 
behavioral, metabolic, neurotrophic, and vascular factors (Vink et al., 1999; Oates, 2002; 
Vincent, et al., 2002; Perkins, et al., 2003). The vascular concept of peripheral diabetic 
neuropathy implies that diabetes-induced endothelial dysfunction with a resultant decrease 
in nerve blood flow, vascular reactivity, and endoneurial hypoxia plays a key role in 
functional and morphological changes in the diabetic nerve (Cameron et al., 2001). 
Endothelial changes in the vasa nervorum have been attributed to multiple mechanisms, 
including increased aldose reductase activity, nonenzymatic glycation and glycoxidation, 
activation of protein kinase C, oxidative–nitrosative stress, and changes in arachidonic acid 
and prostaglandin metabolism (Cameron et al., 2001). The complex and interrelated effects 
of hyperglycemia include increased metabolic flux through the polyol pathway with 
consequent sorbitol and fructose accumulation and reduced sodium-potassium ATPase 
levels, altered fatty acid metabolism, alterations in the redox state, reduced myoinositol and 
sodium-potassium ATPase activity, accumulation of advanced glycated end products, 
accelerated neuronal apoptosis, immunological alterations, changes in blood flow, and 
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increased oxidative stresses. The exact mechanisms of DPN are uncertain, but may involve 
activation of the polyol pathway due to hyperglycemia; the polyol pathway is considered to 
play a major role in diabetic neuropathy (Greene, et al., 1987). Excellent reviews of this 
information are available in previous publications.  
4. NCS 
Diagnosis of DPN on clinical grounds alone is not accurate, and it is difficult to detect small 
alterations in neuropathies (Feldman et al, 1994; Perkins et al, 2001). Therefore, as a 
surrogate measure, NCS are widely used as an evaluation of DPN. NCS measure the ability 
of peripheral nerves to conduct electrical signals, and this ability is impaired when 
pathological changes are present in the myelin, nodes of Ranvier, and axons. Routine NCS 
include evaluation of the motor function of the median, ulnar, peroneal, and tibial nerves, 
and evaluation of the sensory function of the median, ulnar, radial, and sural nerves. 
Velocities are universally reported in meters per second, motor amplitudes in millivolts, and 
sensory amplitudes in microvolts. These measurements of upper- and lower-limb motor and 
sensory nerve functions show the presence, distribution, and severity of peripheral nerve 
disease (Albers, et al., 1995).  
The attribution of peripheral nerve dysfunction to either primary demyelination or primary 
axonal loss is usually based on nerve conduction velocity and action potential amplitude 
data. In general, demyelination is indicated by a decreased nerve conduction velocity, 
conduction block, or increased temporal dispersion, whereas axonal loss is indicated by a 
reduction in the amplitude or area of the sensory nerve action potential (SNAP) or  
compound muscle action potential (CMAP). However, there has been considerable 
disagreement in terms of the clinical and the electrophysiological criteria for the diagnosis of 
DPN.  
Recently, various calculated indices such as the residual latency, terminal latency index, and 
modified F-wave ratio were introduced as more sensitive electrophysiological tools than a 
conventional NCS in patients with diverse types of peripheral neuropathies (Attarian et al, 
2001; Kaplan, et al, 1978; Radziwill et al, 2003).  
5. Sonography 
5.1 Sonographic features of normal peripheral nerves 
US is a widely utilized diagnostic tool for gynecological purposes and examinations of the 
heart and intra-abdominal and superficial organs. With the advancement of sonographic 
resolution, normal peripheral nerves also can be clearly demonstrated. US is a useful 
technique for the investigation of a number of musculoskeletal disorders. Although US has 
the well-known advantages of low cost, accessibility, portability, noninvasiveness, and 
multiplanar imaging, one of its most important diagnostic advantages over other techniques 
is considered to be its real-time imaging capability, allowing for dynamic evaluation of the 
musculoskeletal field (Khoury et al., 2007).   
US can be used to determine the location, extent, type of lesion as well as the presence of 
nerve swelling and inflammation. Major peripheral nerves in the extremities, such as the 
median, ulnar, radial, sciatic, and posterior tibial nerves can be seen using conventional US 
performed with 5- to 12-MHz probes (Stokvis et al., 2009). In controls, peripheral nerves are 
seen as hypoechoic neuronal fascicles surrounded by echogenic connective tissue (Silvestri 
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et al., 1995). The basic units of the peripheral nerve consist of a neural fiber embedded in the 
endoneurium. Because the endoneurium is too thin to reflect the sound beam, it is 
hypoechogenic on the US scan. The neural fascicle consists of several neural fibers and is 
embedded in a capsule called the perineurium. This capsule consists of connective tissue, 
vessels, and lymphatic ducts and is thick enough to reflect the sound beam, resulting in 
hyperechoic lines on the US scan. The trunk of the peripheral nerve consists of several 
neural fascicles and is embedded in a thicker membrane called the epineurium, which is 
seen as bold echogenic lines on the US. Therefore, a peripheral nerve is seen as several 
parallel hyperechoic lines and bold hypoechoic lines on longitudinal images and as a 
faveolate pattern on transverse images (Fig 1).  
 
 (a) 
 (b) 
 (c) 
Fig. 1. Sonographic imaging of the median nerve. Transverse sonogram of the median nerve 
in 5cm proximal to the wrist (a), and longitudinal sonogram of the median nerve  (b). Multi-
slice views using three-dimensional volumetric ultrasonography images (c). The transverse 
planes at continuous segment of the median nerves are visualized. 
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5.2 Sonographic features of the peripheral nerves in patients with type 2 DM 
We previuosly reported that peripheral nerves in patients with low MCV and type 2 DM 
showed enlarged and hypoechoic patterns as compared with those of controls or patients 
with high MCV and type 2 DM. There are 2 sonographic methods of measuring nerve CSA: 
the indirect method (ellipsoid formula) and direct method (tracing). Recently, Alemán et 
al.(2008) reported that median nerve CSA measurements are reproducible by either the 
direct or indirect method when a standardized ultrasonographic examination protocol is 
applied. Sernik et al. (2008) also reported a high correlation (r = 0.99) between the areas 
calculated by the indirect and direct methods. 
In patients with DPN, peripheral nerves showed enlarged and hypoechoic patterns. Figure 2 
shows sonographic images of several nerves in the controls and in patients with type 2 DM. 
The CSAs of the median, ulnar, and tibial nerves in patients with DM were significantly 
larger than those in controls. It is likely that these findings reflect the pathological changes, 
although the pathogenesis of nerve enlargement and increased percentage of the hypoechoic 
area in peripheral nerves is uncertain because our study did not include histological 
evidence. In a 1H-nuclear magnetic resonance study, Suzuki et al. (1994) reported that 
sorbitol and the sodium accumulation caused by an increase in sorbitol may be major 
contributors to the increase in intracellular hydration. It has further been hypothesized that 
peripheral nerves are swollen in individuals with DM because of increased water content 
related to an increase in the aldose reductase-mediated conversion of glucose to sorbitol. We 
hypothesize that the increase in the hypoechoic area of peripheral nerves in diabetic patients 
may be because of increased water content, which is also a cause of enlargement of 
peripheral nerves. 
5.3 Assessment of the internal echo of the peripheral nerves 
The ultrasonographic images of the peripheral nerves were saved as JPEG files and 
transferred to a personal computer for analysis. The monochrome US image was quantized 
to 8 bits (i.e., 256 gray levels). The brightness of the pixels ranged from 0 (black) to 255 
(white). Histogram analysis in US has been expected to offer an objective index for 
estimating the echo intensity, such as in the diagnosis of fatty liver or hepatitis (Lee et al., 
2006; Osawa et al., 1996). The region of interest was set to cover the entire nerve, excluding 
its hyperechoic rim. We used the percentage of the hypoechoic area as the index after the 
effects of gain shift on echo intensity in the median nerve were confirmed (Fig. 3). 
The normal appearance of a peripheral nerve should be readily recognized. Peripheral 
nerves consist of multiple hypoechoic bands corresponding to neuronal fascicles, which 
are separated by hyperechoic lines that correspond to the epineurium. Thus, the value 
obtained by the discriminant analysis method of Otsu was used as a threshold level for 
the analysis of the percentage of the hypoechoic area because the echogenicity of 
peripheral nerves was obtained as a graded echo density from black to white. Otsu’s 
method (1979), which selects a global threshold value by maximizing the separability of 
the classes in gray levels, is one of the better tequniques for image segmentation. 
Mathematically, this can be expressed as: 
 pi = 
fi
N , pi ɪ 0, 
i=1
L
pi = 1. (1) 
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Fig. 2. Comparison of the nerves in controls and in diabetic patients. Transverse image of the 
median nerve in control’ wrist (a), and in diabetic patient’s wrist (b). Transverse image of 
the ulnar nerve in control’ wrist (c), and in diabetic patient’s wrist (d).  Transverse image of 
the tibial nerve in control’ ankle (e), and in diabetic patient’s ankle (f). Transverse sonogram 
of the sural nerve in control’ ankle (g), and in diabetic patient’s ankle (h). 
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Fig. 3. The effects of the gain shift on the echo intensity in the median nerve. Open bars 
showed a change of mean, closed bars showed a change of SD, and solid line connecting 
solid circles showed a change of percentage according to the gain shift. 
Assume that the image can be represented in L gray levels (1, 2,…, L). If the number of pixels 
at level i is denoted by fi, then the total number of pixels equals N = f1 + f2 + …+fL. If an 
image can be divided into 2 classes (C1 and C2) by a threshold at level t, where class C1 
consists of gray levels from 0 to t, and class C2 contains the other gray levels with t + 1 to L, 
then the cumulative probabilities (w1 and w2) and mean levels (μ1 andμ2) for classes C1 and 
C2, respectively, are given by 
 w1  = 
i=1
ｔ
pi , (2) 
 w2  = 
i=t+1
L
pi , (3) 
and 
 μ1  = 
i=1
ｔ
ipi/w1 , (4) 
 μ2  = 
i=t+1
L
ipi/w2 . (5) 
Otsu selects an optimal threshold t* that maximizes the between-class varianceσ2 B  in Eq. (6) 
based on the discriminant analysis, where μT is the mean intensity of the image. 
 t* = arg 1ɩt＜L max{σ2 B (t)|σ2 B  = w1(μ1 –μT)2 + w2(μ2 –μT)2} (6) 
and 
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 μT  = 
i=1
L
ipi . (7) 
The percentage of the hypoechoic area was studied using computer analysis. Using ImageJ 
software, the amount of the hypoechoic area falling below the threshold echo intensity was 
calculated. In our computerized method, the flowchart of the echo intensity evaluation 
process is demonstrated in Figure 4.  
 
 
Fig. 4. Illustration of the working flow of the evaluation of the echo intensity.  
Representative sonographic images and three-dimensional graphic using ImageJ software of 
diabetic patients and controls are shown in Fig 5.  
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Fig. 5. Distributions of the echo intensity in the median nerve. Transverse sonogram of the 
median nerve in a control participant’s wrist (a). Transverse sonogram of the median nerve 
in a diabetic patient’s wrist (b).Three-dimensional graphic of the distribution of the echo 
intensity in the control’s wrist (c). Three-dimensional graphic of the distribution of the echo 
intensity in the diabetic patient’s wrist (d). Hypoechoic area was displayed “light blue”, and 
hyperechoic area was displayed “pink”. 
6. Sonography and NCS in patients with type 2 DM 
6.1 Relationship between sonography and NCS 
We studied 144 peripheral nerves (40 median, 40 ulnar, 40 tibial, and 24 sural nerves) of 40 
subjects who underwent both US and NCS (unpublished data). Overall, 20 type 2 diabetes 
patients [10 men and 10 women; age range, 50-88 years (mean, 68.5 ± 10.7 years)] and 20 
healthy volunteers [12 men and 8 women; age range, 26-59 years (mean, 40.0 ± 12.3 years)] 
were enrolled in this study. All participants whose wrists had symptoms of carpal tunnel 
syndrome were excluded from the study. This study was approved by the Institutional 
Review Board of Gifu University Hospital, and informed consent was obtained from all 
participants. 
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Ultrasonographic examination was performed by a board-certified sonographer who was 
blinded to the knowledge of the electrodiagnostic results. A 6.0- to 14.0-MHz linear array 
probe was used (portable real-time apparatus: Aplio XG; Toshiba Medical Systems, Japan). 
All subjects were seated on the examination table with their arms on a pillow and fingers 
semi-extended during examination of the median or ulnar nerves, and in the prone position 
during examination of the tibial and sural nerves. The CSA of the median nerve was 
measured at the carpal tunnel (MA) and at 5 cm proximal to the wrist (MB). The CSA of the 
ulnar nerve was measured at 5 cm proximal to the wrist (UA). The CSA of the tibial nerve 
was measured at the posterior medial malleolus (TA). The CSA of the sural nerve was 
measured at the lower third of the crus (SA). US images were quantitatively analyzed using 
the ImageJ software (National Institutes of Health, USA). We evaluated the relationship 
between the US and NCS results.  
Routine NCS were performed using conventional procedures and standard 
electromyography (Neuropack MEB-2200; Nihon Kohden Corp., Japan). All examinations 
were performed in a room with an ambient temperature of 25°C. The skin surface 
temperature in all cases was 31°C to 34°C. Mann-Whitney U test was used to compare 
data between the 2 groups. Pearson’s correlation coefficients were used to investigate the 
correlation of CSA and the percentage of the hypoechoic area with several NCS 
parameters. Results are given as mean ± SD, and statistical significance was assessed at P 
< 0.05. 
The US and NCS results of diabetic patients and controls are shown in Table 1. The CSAs in 
the patients with DM group were 0.13 ± 0.05 cm2 in the MA, 0.09 ± 0.03 cm2 in the MB, 0.0.7 
± 0.02 cm2 in the UA, 0.18 ± 0.04 cm2 in the TA, and 0.05 ± 0.01 cm2 in the SA. The CSAs in 
the controls were 0.08 ± 0.02 cm2 in the MA, 0.07 ± 0.02 cm2 in the MB, 0.04 ± 0.01 cm2 in the 
UA, 0.10 ± 0.03 cm2 in the TA, and 0.04 ± 0.01 cm2 in the SA. The CSAs was a significant 
increase in the diabetic patients compared with that in the controls, with the exception of the 
sural nerve. The percentage of the hypoechoic area was significantly increased in the 
diabetic patients compared with that in the controls (P < 0.05). The MCV and sensory nerve 
conduction velocity of all nerves in the diabetic patients showed a significant decrease 
compared with those in the controls (P < 0.001). The CMAP and SNAP of all nerves in the 
diabetic patients showed a significant decrease compared with those in the controls, with 
exception of the CMAPs of both the median and tibial nerves (P < 0.001). On the other hand, 
distal latency (DL) was significantly lesser in the diabetic patients than in the controls, with 
the exception of the sensory ulnar and motor tibial nerves. 
The relationships between US findings and NCS parameters are shown in Figure 6. The 
motor DL period of the median nerve was divided into 3 groups: DL of <3.5 ms; DL of 3.5 to 
4.0 ms; and DL of >4.0 ms. The MCV of the median nerve was also divided into 3 groups: 
MCV of <50 m/s; MCV = 50 to 55 m/s; and MCV of >55 m/s. The categorization of subjects 
into tertiles of DL yielded 3 separate groups. Compared with the first tertile, the CSAs of the 
median nerve increased significantly with each tertile. Moreover, after combining tertiles of 
DL and MCV, even more comprehensive CSA stratification was possible, with all-cause 
CSA ranging from 0.07 cm2 in subjects in the lowest tertile of both parameters to 0.17 cm2 in 
subjects in the highest tertile (Fig. 6a). The hypoechoic area of the median nerve also 
increased significantly with each tertile. The hypoechoic area of the median nerve 
stratification was 52.5% in subjects in the highest tertile of both parameters (Fig. 6b). These 
results correlated with the electrophysiological severity.   
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Parameters Nerve Controls 
Patients with type 2 
DM 
Sonographic 
measurements (CSA) 
 
MA (cm2) Median 0.08 ± 0.02 0.13 ± 0.05*** 
MB (cm2) Median 0.07 ± 0.02 0.09 ± 0.03** 
UA (cm2) Ulnar 0.04 ± 0.01 0.07 ± 0.02*** 
TA (cm2) Tibial 0.10 ± 0.03 0.18 ± 0.04*** 
SA (cm2) Sural 0.04 ± 0.01 0.05 ± 0.01 
Sonographic 
measurements 
(echo intensity) 
 
MB (%) Median 43.7 ± 5.1 50.0 ± 9.3* 
UA (%) Ulnar 43.6 ± 4.1 49.6 ± 10.6* 
TA (%) Tibial 44.8 ± 4.5 51.4 ± 7.5* 
SA (%) Sural 40.4 ±7.1 48.8 ± 3.7* 
Electrophysiologic 
measurements 
 
MCV (m/s) Median 59.9 ± 4.4 50.7 ± 5.7*** 
DL (ms) Median 3.3 ± 0.5 4.5 ± 1.3*** 
CMAP (mV) Median 11.2 ± 3.7 11.6 ± 4.4 
SCV (m/s) Median 69.1 ± 8.6 57.3 ± 5.7*** 
DL (ms) Median 2.7 ± 0.4 3.3 ± 0.4*** 
SNAP (uV) Median 38.3 ±11.7 12.5 ± 8.3*** 
MCV (m/s) Ulnar 64.7± 6.1 52.1± 6.7*** 
DL (ms) Ulnar 2.5 ± 0.4 2.9 ± 0.5* 
CMAP (mV) Ulnar 14.9 ± 3.8 9.4 ± 2.5*** 
SCV (m/s) Ulnar 72.0 ± 5.4 61.7 ± 10.5*** 
DL (ms) Ulnar 3.3 ± 0.7 3.9 ± 0.8 
SNAP (uV) Ulnar 20.4 ± 10.0 6.3 ± 2.9*** 
MCV (m/s) Tibial 49.4 ± 2.4 40.3 ± 5.1*** 
DL (ms) Tibial 3.9 ± 0.5 4.4 ± 0.9 
CMAP (mV) Tibial 16.1 ± 5.3 13.1 ± 6.9 
SCV (m/s) Sural 55.7± 2.5 49.1± 5.3*** 
DL (ms) Sural 2.5 ± 0.1 2.9 ± 0.3*** 
SNAP (uV) Sural 10.3± 4.1 3.6 ± 2.5*** 
Table 1. US and NCS measurements of controls and patients with type 2 DM (unpublished 
data). 
Mann-Whitney U test: *P<0.05 versus controls; **P<0.01 versus controls; ***P<0.001 versus 
controls. 
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(a)                                                                              (b) 
Fig. 6. Relationships of between US and NCS parameters in the median nerve. Stratification 
of CSA by combining tertiles of DL and MCV (a). Stratification of hypoechoic area by 
combining tertiles of DL and MCV (b).  
6.2 Comparison of diagnostic ability between US and NCS parameters 
 NCS are widely used for the diagnosis of DPN. The examinations are deemed to be 
objective, reliable, and sensitive, and can be used as statistical instruments or surrogate 
endpoints for neuropathy in large clinical investigations of DPN (Diabetes Control and 
Complications Trial Research Group., 1995; Cornblath et al., 1999; Dyck et al., 1991). NCS 
have also been recommended in the medical literature as the “gold standard” with which to 
evaluate and validate other screening tests that are used to diagnose peripheral neuropathy. 
We aimed to determine the best diagnostic criterion for diagnosing DPN by US and NCS. A 
receiver operating characteristic (ROC) curve was generated for each parameter in the US 
and NCS examinations, and areas under the curve (AUC) were determined. The ROC 
curves are plots of the true-positive rate (sensitivity) against the false-positive rate (1.0 – 
specificity) for the different possible cutoff points of a diagnostic test. To determine the 
accuracy of detection of DPN, we calculated  and compared the sensitivity and specificity of 
both US and NCS. 
In our preliminary study, the CSA at TA in the tibial nerve had the best diagnostic accuracy 
for DPN of all the sonographic examinations. The ROC curves of the CSA at TA revealed 
that the AUC was 0.919 (P < 0.001) with an optimal cutoff value of 0.145 cm2, yielding 80% 
sensitivity and 94% specificity. For the NCS, the SNAPs had the best diagnostic accuracy for 
DPN; each nerve had an extremely high AUC (median nerve, 0.971; ulnar nerve, 0.944; and 
sural nerve, 0.938; P < 0.001). These cutoffs also yielded very good sensitivity (93% - 94%) 
and specificity (80% to 92%). Some investigators have reported that sural nerve dysfunction 
is the most common indicator of peripheral nerve dysfunction, is the first to be affected, and 
correlates most closely with the neuropathological findings (Dyck et al., 1985; Dyck., 1988; 
Redmond et al., 1992). Dyck et al. (1985) found that the peroneal motor nerve had the 
highest degree of abnormality, followed by the sural, median sensory, and median motor 
nerves. Karsidag et al. (2005) also reported that the most affected nerves were the sural 
sensory, peroneal motor, posterior tibial motor, median motor, ulnar motor, median 
sensory, and ulnar sensory nerves. In our study, the sural nerve had a high AUG, as 
reported in previous reports. Furthermore, the CSA at TA showed the most effective 
parameter in the US examinations; it was suggested that the most useful and practical 
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nerves for  electrophysiological and sonographical studies in diabetic patients are the lower 
extremity nerves.  
 
 
 
                                            (a)                                                                   (b) 
 
 
 
                                         (c)                                                                     (d) 
 
 
                                         (e)                                                                     (f) 
www.intechopen.com
Recent Advances in the Pathogenesis, Prevention and  
Management of Type 2 Diabetes and its Complications 
 
28
 
                                          (g)                                                                (h) 
Fig. 7. Receiver operating characteristic curves fitted for difference modality. (a) When the 
ROC curve was fitted using CSA results of US, CSA at the TA was most effective. (b) When 
the ROC curve was fitted using hypoechoic area of US, SA at the sural nerve was most 
effective. (c) When the ROC curve was fitted using MCV results of NCS, MCV of the tibial 
nerve was most effective. (d) When the ROC curve was fitted using SCV results of NCS, 
SCV of the sural nerve was most effective. (e) When the ROC curve was fitted using motor 
DL results of NCS, latency of the median nerve was most effective. (f) When the ROC curve 
was fitted using sensory DL results of NCS, latency of the sural nerve was most effective. (g) 
When the ROC curve was fitted using CMAP results of NCS, CMAP of the ulnar nerve was 
most effective. (h) When the ROC curve was fitted using SNAP results of NCS, SNAP of the 
median nerve was most effective.  
According to the ROC curve analysis, to investigate whether the use of US and NCS could 
accurately determine the presence of DPN, we compared the sensitivity and specificity of 
different parameters. Both sensitivity and specificity were higher in NCS than in US. 
These results were consistent with the current status that NCS is widely accepted as the 
more sensitive system of evaluation of polyneuropathy. Although sonographic 
measurements have insufficient sensitivity and specificity compared with those of the 
NCS, the ROC curves showed that AUCs were as high as 0.681 to 0.919, yielding 43% to 
94% sensitivity and 50% to 94 % specificity. We promote the possibility of using 
sonography to diagnose DPN.  
7. Conclusion 
In this chapter, we have reviewed the current knowledge of neuropathy in type 2 DM and 
have introduced a sonographical examination for DPN. Based on our present data, it 
appears that both size and hypoechoic area of nerves were increased in patients with type 2 
DM compared with controls. US is a noninvasive method that can be used to evaluate 
detailed nerve structures. The results from this preliminary study indicate that US might be 
considered as a valuable tool for the evaluation of DPN. In this work, we focused on the 
development of an objective method of quantitative analysis of echogenicity changes in 
peripheral nerves over a clarification of the mechanism. Some limitations of our study 
should be mentioned. First, a relatively small number of participants were studied and no 
adjustments were made for age differences. Second, our study was an ultrasonographic 
examination only; therefore, exactly what causes an increased hypoechoic area or CSA 
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remains unknown. Furthermore, we must describe the property of sound waves. The 
property depends on both the object and the matrix in which it occurs, in that it relates to 
changes in acoustic impedance between 2 abutting structures. It is generally known that 
most nerves, including the median nerve, are surrounded by hyperechoic structures such as 
the tendons and that these hyperechoic structures may affect their appearance. Further 
investigation is required to clarify these findings in larger groups of diabetic patients using 
other modalities, such as magnetic resonance imaging. 
Finally, there is little doubt that NCS are widely accepted as more sensitive than US in the 
evaluation of peripheral nerve disorders. However, US is able to directly show 
morphological changes in the peripheral nerves. Compared with NUS, US caused less 
discomfort to patients and was less time-consuming in our study. For these reasons, we 
promote the possibility of using this technique for the diagnosis of DPN.  
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